Date:
Thu, 11 Jun 2026 11:01:39 EDT
Content:
The U.S. Food and Drug Administration (FDA) has released an Establishment Inspection Report (EIR) following an assessment of Blendhouse Allerton LLC, a manufacturing facility located in Allerton, Iowa.
The report details the findings of an inspection conducted at the Allerton facility. This EIR was officially issued on January 22, 2026, and has been added to the Office of Regulatory Affairs (ORA) FOIA Electronic Reading Room as part of the agency’s commitment to public transparency. As a registered manufacturer, the firm is subject to federal oversight to ensure its operations meet regulatory standards.
Establishment Inspection Reports are typically issued to a firm after the FDA has completed an inspection and determined that the site’s compliance status is documented. This specific record provides stakeholders and the public with insights into the regulatory history of the establishment and the agency’s oversight activities in the state of Iowa.
Source: U.S. Food and Drug Administration
Link:
http://www.fda.gov/about-fda/fda-commissioner/blendhouse-allerton-llc-allerton-ia-eir-issued-01222026
Keywords:
FDA, Blendhouse Allerton LLC, EIR, Inspection Report, Allerton Iowa, Manufacturing Compliance, FOIA Electronic Reading Room